Japan’s Corundum Systems Biology Inc., a company active in unlocking next-generation life science technologies with a focus on the microbiome for human health, will become the main sponsor of the Harvard Chan Microbiome in Public Health Center (HCMPH)’s “Microbial Communities Beyond the Bacteriome” Symposium this year. Fifth in the annual microbiome series at the Harvard T.H. Chan School of Public Health, this year’s Symposium will be held in Boston, Massachusetts, on May 15, 2023.
This 2023 Symposium will highlight the field’s deepened understanding of “often-overlooked non-bacterial microbes that can play unique roles in health and environmental phenotypes,” such as viruses and fungi.
For more details :
About Corundum Innovation
Corundum Innovation Co., Ltd., and Corundum Ventures Ltd. (Hereafter Corundum) provide venture capital (VC) investment and consulting services to investors for both financial and strategic returns. Corundum provides flexible services to COIF’s investors for new business development in various phases with our expertise in science, technology, business development, corporate management, finance and consulting, as well as our strong network with top Israeli VC and the valuable information we can access through fund activities. Corundum’s support includes information gathering, negotiation for partnership, direct investment, market development, HR development, and fund formation.
Corundum Innovation Co., Ltd.